Of the tracked stories, 2 of 2 also mention Centers for Medicare & Medicaid Services, the most common co-covered peer. Coverage clusters in markets, which accounts for 1 of those 2, with the remainder spread across 1 other category. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Medicare Advantage
Of the tracked stories, 2 of 2 also mention Centers for Medicare & Medicaid Services, the most common co-covered peer. Coverage clusters in markets, which accounts for 1 of those 2, with the remainder spread across 1 other category. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. At 5.5, the average consequence score sits below the same-window beat average of 5.6. Medicare Advantage appears in 2 tracked Finance stories published from August 14, 2026 through August 19, 2026.
Stories tracked
2
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 144 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Medicare Advantage. Shared-story counts are live from our verified record — not editorial picks.
Costco is adding Medicare Advantage distribution via SCAN Health Plans in a three-market pilot. For investors, the deal represents optionality in senior-focused health revenue with limited initial capital commitment, though timeline and geographic disclosure remain uncertain.
New federal transparency data provides the first comparable prior authorization denial rates for public plan insurers. Outliers UnitedHealth at 17% in Medicare Advantage and Centene at 25% in ACA Marketplace face reputation and regulatory risk, while low-denial plans may gain a competitive edge.